Melatonin, an inhibitory agent in breast cancer.

Melatonin, an inhibitory agent in breast cancer.

Item
http://www.wikidata.org/entity/Q30489143
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis.Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat.Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Sleep, Melatonin, and the Menopausal Transition: What Are the Links?Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation.Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction
P2860

Melatonin, an inhibitory agent in breast cancer.

Item
http://www.wikidata.org/entity/Q30489143
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Melatonin, an inhibitory agent in breast cancer.
@ast
Melatonin, an inhibitory agent in breast cancer.
@en
type
label
Melatonin, an inhibitory agent in breast cancer.
@ast
Melatonin, an inhibitory agent in breast cancer.
@en
prefLabel
Melatonin, an inhibitory agent in breast cancer.
@ast
Melatonin, an inhibitory agent in breast cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Melatonin, an inhibitory agent in breast cancer
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921